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Abstract  Gastrointestinal  endoscopy  and  the  acquisition  of  tissue  samples  are  essential  for
the diagnosis  and  treatment  of  various  diseases  of  the  digestive  system.  However,  given  the
differences  between  the  recommendations  and  the  clinical  practice,  the  inexorable  increase  of
requests for  endoscopic  examinations  and  the  ﬁnancial  burden  associated  with  it,  it  is  crucial
that we  concentrate  on  the  challenge  that  endoscopic  biopsies  represent.  In  this  review  we
describe  the  available  evidence  in  the  literature,  including  the  more  recent  published  guide-
lines, on  when  or  not  to  perform  endoscopic  biopsies  in  upper  and  lower  endoscopy,  focusing
on the  precise  diagnosis  of  the  most  common  gastrointestinal  diseases  that  motivate  endo-
scopic examinations  and  on  the  rational  use  of  available  resources  without  compromising  proper
management  of  patients.
© 2015  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Biópsias  em  Endoscopia  Digestiva:  Quando  e  Como  Fazê-las
Resumo  A  endoscopia  digestiva  e  a  aquisic¸ão  de  amostras  tecidulares  são  essenciais  para  o
diagnóstico e  tratamento  de  diversas  patologias  do  tubo  digestivo.  No  entanto,  tendo  em  conta
a diferenc¸a  entre  as  recomendac¸ões  e  a  prática  clínica,  o  inexorável  aumento  de  pedidos  de
exames endoscópicos  e  os  encargos  ﬁnanceiros  associados,  é  fundamental  que  nos  debrucemos
sobre o  desaﬁo  que  as  biópsias  endoscópicas  representam.  Nesta  revisão,  pretendemos  descr-
ever a  evidência  disponível  na  literatura,  incluindo  as  mais  recentes  guidelines  publicadas,
sobre quando  ou  não  realizar  biópsias  em  endoscopia  digestiva  alta  e  baixa,  com  foco  no  diag-
nóstico das  mais  comuns  doenc¸as  gastrointestinais  que  motivam  exames  endoscópicos,  e  no  uso
níveis,  sem  comprometer  o  bom  acompanhamento  dos  doentes.
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. Introduction
astrointestinal  endoscopy  and  the  acquisition  of  tissue
amples  are  essential  for  the  diagnosis  and  treatment  of  var-
ous  diseases  of  the  digestive  system.  Given  the  differences
etween  the  recommendations  and  the  clinical  practice,
he  inexorable  increase  of  requests  for  endoscopic  exam-
nations  and  the  ﬁnancial  burden  associated  with  it,  it  is
ssential  that  we  concentrate  on  the  challenge  that  endo-
copic  biopsies  represent.  In  order  to  rationalize  the  use  of
istopathological  examinations,  it  is  crucial  to  understand
hy  some  gastroenterologists  perform  biopsies  more  often
han  others.  One  possible  explanation  relates  to  the  evi-
ence  that  clinicians  with  less  experience  are  more  likely  to
erform  unnecessary  biopsies.1
Another  crucial  point  is  the  communication  with  the
natomopathologists.  The  histological  opinion  is,  as  the
adiological  opinion,  entirely  dependent  on  the  clinical
nformation  provided  and  the  questions  that  are  being
sked.  As  such,  it  is  essential  that  each  endoscopy  unit
evelop,  in  conjunction  with  the  pathology  departments,
imple  guidance  on  what  information  provide  on  requisi-
ions.
In  this  review  we  describe  the  available  evidence  in  the
iterature,  including  the  more  recent  guidelines  published,
n  when  or  not  to  perform  endoscopic  biopsies  in  upper
nd  lower  endoscopy.2,3 These  are  pragmatic  approaches
hat  are  based  on  the  principle  that  the  biopsies  should  be
erformed  only  when  have  potential  to  change  the  future
pproach  to  the  patient.  However,  it  is  necessary  to  admit
hat  in  certain  conditions  the  available  evidence  does  not
llow  to  establish  strong  recommendations  and,  in  such
ases,  it  is  upon  the  gastroenterologist  decision-making
bout  the  cost-beneﬁt  of  biopsies.4
Tables  1  and  2  summarize  the  proposals  to  perform  biop-
ies  in  upper  and  lower  endoscopy,  respectively.
. Upper endoscopy
.1.  Gastroesophageal  reﬂux  disease
astroesophageal  reﬂux  disease  (GERD)  is  an  extremely
ommon  pathology.  It  is  estimated  that  approximately  15%
f  the  population  of  the  United  States  presents  symptoms  of
hronic  reﬂux.5 The  most  common  complication  of  GERD  is
sophagitis,  observed  in  20%  of  the  individuals  submitted  to
ndoscopy  in  western  countries.  However,  the  weak  correla-
ion  between  endoscopic  and  histologic  ﬁndings  prevents  the
eﬁnition  of  a  biopsies  protocol  in  this  situation.  The  clinical
mplication  of  histological  abnormalities  in  patients  without
acroscopic  changes  is  unknown,  and  the  biopsies  should
e  directed  only  to  irregularities  of  the  mucosa,  if  clinically
ppropriate.6 Also,  performing  endoscopic  biopsies  in  an
sophageal--gastric  junction  with  inﬂammatory  signs  with-
ut  other  changes  reﬂects  a  situation  often  associated  with
nnecessary  use  of  resources.  If  the  histological  examina-
ion  reveals  intestinal  metaplasia  in  this  context  (ultra-short
egment  Barrett’s  esophagus),  the  clinical  signiﬁcance  and
he  follow-up  to  be  done  are  unknown,  by  which,  in  this
ituation,  the  biopsy  is  not  recommended.7
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.2.  Barrett’s  esophagus
he  most  worrying  histological  complication  in  GERD  is
he  development  of  Barrett’s  esophagus,  in  particular  by
ts  association  with  esophageal  adenocarcinoma  (20  times
ncreased  risk),  whose  incidence  has  increased.8 Barrett’s
sophagus  is  identiﬁed  endoscopically  and  histologically
onﬁrmed  by  the  replacement  of  the  normal  mucosa  of  the
istal  esophagus  by  metaplasic  columnar  epithelium,9 and
s  currently  the  main  cause  for  esophageal  biopsies.  Prague
lassiﬁcation  is  recommended  to  describe  the  extension  of
he  Barrett’s  esophagus,  taking  as  a  point  of  reference  the
roximal  limit  of  the  gastric  folds.10 The  presence  of  intesti-
al  metaplasia  and  the  extent  of  the  changes  determine
he  subsequent  follow-up.  Seattle  protocol  has  been  broadly
sed  in  the  characterization  of  lesions  compatible  with  Bar-
ett’s  esophagus,  and  there  is  evidence  that  its  adoption
ncreases  the  success  rate  of  the  endoscopic  diagnosis,  in
articular  the  detection  of  dysplastic  changes.11 The  proto-
ol  consists  in  performing  biopsies  in  the  four  quadrants  at
ach  2  cm.  In  agreement  with  the  histological  ﬁndings,  the
ollow-up  should  be  the  following:
 In  Barrett’s  esophagus  without  dysplasia  it  is  recom-
mended  to  perform  biopsies  of  the  four  quadrants  at  each
2  cm  every  3--5  years;
 In  Barrett’s  esophagus  with  low  grade  dysplasia  it  is  rec-
ommend  to  perform  biopsies  of  the  four  quadrants  at  each
1--2  cm  every  6--12  months;
 In  Barrett’s  esophagus  with  high-grade  dysplasia  it  is  rec-
ommended  to  perform  biopsies  of  the  four  quadrants  each
1  cm  every  three  months,  in  the  absence  of  treatment  for
its  eradication.
Short  segments  (<3  cm)  without  intestinal  metaplasia
hould  not  be  followed  after  a  second  endoscopy  conﬁrming
he  absence  of  metaplasia.4
.3.  Eosinophilic  esophagitis
he  incidence  of  eosinophilic  esophagitis  has  been  increas-
ng  in  recent  decades.  Population-based  studies  suggest
revalence  greater  than  1:1000  individuals,  with  higher  inci-
ence  in  males,  and  there  is  a  clear  association  with  other
topic  pathologies.12 The  main  symptoms  include  dysphagia
nd  food  impaction,  and  its  diagnosis  requires  the  integra-
ion  of  clinical,  endoscopic  and  histological  features.4 The
istological  ﬁndings  may  be  discontinuous  in  its  distribution
nd  a variable  number  of  eosinophils  per  high  power  ﬁeld
ave  been  reported.  The  studies  revealed  that  the  com-
letion  of  3--6  biopsies  presents  sensitivity  between  97  and
00%  when  using  a  cut-off  of  15  eosinophils  per  high  power
eld.13 It  is  important  to  mention  that  other  conditions  may
resent  eosinophilia  of  the  esophageal  mucosa,  in  particular
ERD,  although  in  this  case  it  is  expected  to  be  limited,  or
ore  exuberant,  in  distal  esophagus.  As  such,  the  scheme
f  biopsies  most  universally  accepted  consists  in  perform-
ng  two  to  four  biopsies  of  the  proximal  esophagus,  two  to
our  biopsies  of  the  distal  esophagus  and  biopsies  of  the  gas-
ric  antrum  and  duodenum  in  suspected  cases  of  eosinophilic
astroenteritis.14 In  the  presence  of  eosinophilia  compatible
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Table  1  Summary  of  recommendations  for  biopsies  in  upper  endoscopy.
Disease  Recommendations  Comments
Gastroesophageal
reﬂux  disease
--Biopsies  directed  to  irregularities  of  the  mucosa,
if clinically  appropriate
--Biopsies  in  a  esophageal--gastric  junction
with  inﬂammatory  aspects  are  not
recommended
Barrett’s
esophagus
Protocol  of  Seattle
--Barrett’s  esophagus  without  dysplasia:  biopsies  of
4 quadrants  each  2  cm
--Barrett’s  esophagus  with  low  grade  dysplasia:
biopsies  of  4  quadrants  each  1--2  cm
--Barrett’s  esophagus  with  high-grade  dysplasia:
biopsies  of  4  quadrants  each  1  cm
--Short  segments  (<3  cm)  without
metaplasia  should  not  be  followed  after  a
second  endoscopy  without  metaplasia
Eosinophilic
esophagitis
--Two to  four  biopsies  of  the  proximal  esophagus
--Two to  four  biopsies  of  the  distal  esophagus
--Biopsies  of  the  gastric  antrum  and
duodenum  if  there  is  suspicion  of
eosinophilic  gastroenteritis
Infectious
esophagitis
CMV infection
--Biopsies  from  the  base  of  the  ulcers
HSV infection
--Biopsies  from  the  edges  of  the  ulcers
Esophageal  candidiasis
--Biopsies  from  affected  areas  +  exfoliative  cytology
Helicobacter
pylori
Histological  diagnosis
--Protocol  of  Sidney:
(1)  One  biopsy  from  the  lesser  curvature  of  the
antrum  within  2--3  cm  of  the  pylorus
(2)  One  biopsy  from  the  greater  curvature  of  the
antrum  within  2--3  cm  of  the  pylorus
(3)  One  biopsy  from  the  lesser  curvature  of  the
body  8  cm  from  the  cardia
(4)  One  biopsy  from  the  greater  curvature  of  the
body  8  cm  from  the  cardia
(5)  One  biopsy  from  the  incisura  angularis
--Three  biopsies  protocol  (alternative):  one  biopsy
from  the  incisura  angularis,  one  biopsy  from  the
greater  curvature  of  the  body,  one  biopsy  from  the
greater curvature  of  the  antrum
--If  the  search  for  H.  pylori  infection  is
positive,  according  to  family  history,
perform  the  protocol  for  environmental
metaplastic  atrophic  gastritis
--Alternative  strategy  in  special  cases  (e.g.,
poor  tolerance  during  the  procedure)
Environmental
metaplastic
atrophic
gastritis
Protocol of  12  targeted  biopsies
One biopsy  from  each  quadrant  of  the  antrum
Two  biopsies  from  the  incisura  angularis
Four  biopsies  from  the  body  (lesser  and  greater
curvatures)
Two biopsies  from  the  cardia
--Alternative  approach:  seven  random
biopsies  from  the  gastric  cavity
--Autoimmune  atrophic  metaplastic
gastritis:  biopsies  if  suspected  endoscopic
lesions
Gastric polyps  Solitary  polyps
--Polypectomy  whenever  possible;  alternative,
representative  biopsies
--All  adenomatous  polyps,  fundic  gland  polyps
>1 cm  and  hyperplastic  polyps  >2.5  cm  should  be
removed
Multiple  polyps
--The  largest  polyp  should  be  removed
--Representative  biopsies  from  the  smaller  polyps
Hyperplastic  and  adenomatous  polyps
--Protocol  for  environmental  metaplastic  atrophic
gastritis
--Biopsies  of  the  surrounding  mucosa
Peptic  ulcer
disease
--Multiple  biopsies  (≥8)  from  the  base  and  edges  if
there is  suspicion  of  malignancy
--Search  for  H.  pylori  infection
Celiac disease  --Four  to  six  biopsies  from  the  duodenal  bulb  and
distal  duodenum
--Do  not  perform  biopsies  if  minor
abnormalities  of  the  duodenal  mucosa
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Table  2  Summary  of  recommendations  for  biopsies  in  lower  endoscopy.
Disease  Recommendations  Comments
Microscopic  colitis Colonoscopy
--Two  or  more  biopsies  from  the  ascending
colon
--Two or  more  biopsies  from  the  transverse
colon
--Two or  more  biopsies  from  the  descending
colon
--Two or  more  biopsies  from  the  sigmoid  colon
Or
--At least  three  to  four  biopsies  from  both  the
right and  left  colon
--Biopsies  from  the  distal  colon  and  rectum
does  not  always  reveal  diagnostic  ﬁndings
--If a  previous  ﬂexible  sigmoidoscopy  is  not
diagnostic  and  the  clinical  suspicion  is  high,
a colonoscopy  should  be  performed
Inﬂammatory  bowel
disease
(diagnosis)
Ileocolonoscopy
--Two  or  more  biopsies  from  ﬁve  different
locations,  including  the  ileum  and  rectum
Upper  endoscopy
--Two  ou  more  biopsies  from  the  esophagus,
stomach  and  duodenum
--In  the  presence  of  macroscopic  changes,
biopsies  should  be  performed  in  the
affected  areas  and  in  the  apparently
normal  mucosa
Inﬂammatory  bowel
disease
(screening  for
dysplasia)
Chromoendoscopy  (targeted  biopsies)
--Additional  biopsies  from  all  segments  of  the
colon to  assess  the  presence  and  degree  of
inﬂammation
Random  biopsies
--Pancolitis:  biopsies  from  the  four  quadrants
each  10  cm
--Segmental  colitis:  biopsies  from  the  four
quadrants  each  10  cm  limited  to  involved  areas
in previous  examinations
--The  ileocecal  valve  should  not  be  biopsied
if macroscopically  normal
Pouchitis --Multiple  biopsies  from  the  pouch  and  afferent
loop
Colonic  polyps  --Small  polyps  (<5  mm)  can  be  removed  with
biopsy forceps
--Larger  polyps  (>2.5  cm)  should  be  removed  by
polypectomy/mucosectomy
--Biopsies  from  polyps  with  a  high
probability  of  being  removed  may  lead  to
submucosal  ﬁbrosis  and  ﬁx  lesions  that
were  previously  deployable
Acute graft  versus
host  disease
Flexible  sigmoidoscopy
--Four  or  more  biopsies  from  the
rectum/sigmoid  and  four  or  more  biopsies
from  the  left  colon
Ileocolonoscopy
--Four  or  more  biopsies  from  the  terminal
ileum,  ascending  colon,  transverse  colon,
descending  colon  e  rectum/sigmoid  colon.
--The  rectum  and  distal  colon  are  the
locations  with  the  highest  sensitivity
--In case  of  non-diagnostic  ﬂexible
sigmoidoscopy,  an  upper  endoscopy  should
be performed  with  four  or  more  biopsies
from  the  gastric  body,  antrum  and
duodenum.
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rial  of  eight  weeks  with  a  pump  inhibitor  proton.
.4.  Infectious  esophagitis
ith  the  increasing  use  of  immunosuppressants  in  the
ontext  of  organ  transplantation  and  chronic  inﬂamma-
ory  diseases,  in  oncological  situations  with  need  of
hemotherapy  and  with  the  epidemic  infection  by  the
uman  immunodeﬁciency  virus  (HIV),  infections  caused
y  pathogens  such  as  cytomegalovirus  (CMV),  human  her-
esvirus  (HSV)  and  Candida  spp.  have  become  relatively
ommon.  Viral  esophagitis  presents  macroscopically  as
p
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flcerated  lesions.  CMV  infects  predominantly  columnar
ells,  and  biopsies  directed  to  the  base  of  the  ulcers
ncreases  the  diagnostic  accuracy.  Although  there  are  not
 stipulated  minimum  number  of  biopsies,  the  obtaining  of
hree  samples  has  a  sensitivity  of  at  least  80%.  The  qualita-
ive  research  of  CMV  by  polymerase  chain  reaction  (PCR)
as  a  higher  sensitivity  than  the  histopathological  evalu-
tion,  although  it  does  not  distinguish  a  latent  infection
rom  a  clinically  signiﬁcant  one.15 In  contrast  to  CMV,  HSV
nfects  mainly  the  squamous  epithelial  cells,  and,  in  sus-
ected  cases,  the  biopsies  should  be  oriented  toward  the
dges  of  the  ulcers.  The  analyses  by  PCR  or  viral  culture  may
elp  in  establishing  the  diagnosis.16 Candida  colonization  is
requency  in  the  oropharynx,  but  it  may  become  pathogenic
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and  cause  esophagitis  in  immunocompromised  individuals.
Candida  albicans  is  the  most  common  species.  In  suspected
esophageal  candidiasis,  it  is  recommended  to  perform  mul-
tiple  biopsies  of  the  affected  area.  The  complementation
of  biopsies  with  an  exfoliative  cytology  may  increase  the
diagnostic  sensitivity.17
2.5.  Helicobacter  pylori  infection
Gastric  infection  by  Helicobacter  pylori  (H.  pylori) is  the
main  cause  of  peptic  ulcer  disease,  and  has  an  important
role  in  the  pathogenesis  of  MALT  lymphoma  and  gastric
adenocarcinoma.18 The  choice  of  the  diagnostic  approach
depends  heavily  on  the  clinical  situation,  costs  and  local
expertise.  The  endoscopy  based  tests  include  tissue  activ-
ity  of  urease  (faster  and  cheaper,  sensitivity  and  speciﬁcity
greater  than  90--95%),  histological  evaluation  (sensitivity
80--90%  and  speciﬁcity  >95%)  and  cultural  test  (expensive,
time-consuming,  allows  antimicrobial  sensitivity  testing).
Whenever  possible,  we  should  opt  for  the  urease  test.2,4 In
this  situation,  it  is  recommended  that  one  or  two  biopsies
are  taken  5  cm  proximal  to  the  pylorus,  in  the  lesser  cur-
vature  near  the  incisura  angularis  or  in  the  great  curvature
opposite  to  the  incisura  angularis.19 However  it  is  important
to  take  into  account  that  in  the  presence  of  therapy  with  a
proton  pump  inhibitor  (PPI),  bismuth  or  antibiotics,  and  in
the  context  of  upper  gastrointestinal  bleeding,  the  sensitiv-
ity  of  this  rapid  test  decreases  considerably.  As  such,  in  these
situations,  it  should  be  considered  the  histological  evalua-
tion  if  the  urease  test  is  negative.2 PPIs  should  be  stop  at
least  one  week  before  the  endoscopy.  The  histopathological
diagnosis  does  not  yet  have  a  generally  accepted  biopsies
protocol.  The  most  recent  literature  describes  basically  two
optional  approaches,  both  with  similar  sensitivity:
o  Three  biopsies  approach,  including  the  incisura  angularis,
the  great  curvature  of  the  body  and  the  great  curvature
of  the  antrum2;
o Protocol  of  Sydney,  which  includes  ﬁve  biopsies  encom-
passing  the  lesser  curvature  of  the  antrum  within  2--3  cm
of  the  pylorus,  the  great  curvature  of  the  antrum  within
2--3  cm  of  the  pylorus,  the  lesser  curvature  of  the  body
8  cm  distal  to  the  cardia,  the  great  curvature  of  the  body
8  cm  distal  to  the  cardia,  and  the  incisura  angularis.20
Sidney  protocol  presents  the  theoretical  advantage  of
identifying  the  micro-organism  in  individuals  with  chronic
gastritis  with  more  than  15--20  years  of  evolution  with
atrophic  changes  in  the  antrum  and  consequent  reduction  of
H.  pylori  population  in  this  location.  If  the  search  of  H.  pylori
infection  is  positive,  it  is  recommended  to  perform  biop-
sies  for  screening  of  metaplasic  atrophic  gastritis.2 In  the
absence  of  another  reason  for  a  new  endoscopy,  the  conﬁr-
mation  of  eradication  should  be  made  through  non-invasive
methods.
2.6.  Environmental  metaplastic  atrophic  gastritisBy  the  age  of  70,  virtually  all  individuals  present  with  chronic
gastritis.  The  environmental  metaplastic  atrophic  gastritis
(or  chronic  gastritis  type  B)  is  the  most  common  form,  and  H.
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ylori  infection  is  in  the  genesis  of  its  development.  Histor-
cally  described  as  ‘‘predominantly  antral’’,  it  is  estimated
hat  the  conversion  into  pangastritis  is  dependent  on  the
ime  of  evolution,  and  it  occurs  after  15--20  years.21 The
iopsies  in  this  context  aim  to  establish  the  diagnosis,  deﬁne
he  origin  and  distribution  of  the  disease  and  to  evaluate  the
resence  and  extent  of  dysplastic  or  neoplastic  changes.2 In
he  absence  of  risk  factors  such  as  family  history  of  dyspla-
ia  or  gastric  cancer,  biopsies  for  histological  evaluation  of  a
tomach  without  changes  or  endoscopic  aspects  suggestive
f  gastritis  are  not  necessary.4 But  in  the  presence  of  family
istory,  especially  in  the  presence  of  H.  pylori  infection,  it  is
urrently  necessary  to  rule  out  the  presence  of  metaplastic
trophic  gastritis.  The  best  available  evidence  is  described
or  two  optional  approaches:
 Seven  random  biopsies  of  the  stomach  fundus,  body  and
antrum22;
 Twelve  biopsies  protocol:  one  in  each  quadrant  of  the
antrum  (2--3  cm  from  the  pylorus),  two  of  the  incisura
angularis,  four  of  the  body  (lesser  and  great  curvature)
and  two  of  the  cardia.3
The  protocol  for  environmental  metaplastic  atrophic  gas-
ritis  should  be  sufﬁcient  for  the  histological  diagnosis  of  H.
ylori  infection.2
.7.  Autoimmune  atrophic  metaplastic  gastritis
utoimmune  atrophic  metaplastic  gastritis  (or  chronic  gas-
ritis  type  A)  affects  mainly  the  gastric  fundus  and  body,
paring  the  antrum.  Traditionally,  this  form  of  gastritis
s  associated  with  pernicious  anemia  in  the  presence  of
irculating  anti-parietal  cells  and/or  anti-intrinsic  factor
ntibodies  (hence  the  term  ‘‘autoimmune’’),  and  presents
n  increased  risk  of  adenocarcinoma  and  carcinoid  tumors.21
s  there  is  no  described  endoscopic  approach  deﬁned  for
hese  cases,  it  should  be  individualized.  The  biopsies  should
e  directed  to  the  presence  of  ulcers,  nodules,  polyps  or
asses  for  exclusion  of  malignancy.2
.8.  Gastric  polyps
astric  polyps  are  usually  asymptomatic  and  discovered
ccidentally.  The  gastric  epithelial  polyps  can  be  classiﬁed
s  fundic  glands  polyps  (risk  of  malignancy  in  the  context  of
amilial  adenomatous  polyposis),  hyperplastic  polyps  (foci  of
ysplasia  in  up  to  20%  of  cases),  adenomatous  polyps  (higher
isk  of  malignancy)  or  neuroendocrine  tumors  (NETs).2 The
ncidence  and  signiﬁcance  of  gastric  polyps  differ  among
hemselves  and  between  the  different  populations.  The
ecreased  incidence  of  H.  pylori  infection  reduced  the  inci-
ence  of  hyperplastic  and  adenomatous  polyps.18 On  the
ther  hand,  the  increased  chronic  use  of  PPIs  has  been  asso-
iated  with  an  increasing  incidence  of  fundic  glands  polyps.2
In  the  presence  of  solitary  polyps,  it  is  recommended  that
hey  should  be  submitted  to  biopsy  or  removed.  The  follow-
ng  approach  will  be  determined  by  the  histology.  All  the
denomatous  polyps,  the  fundic  glands  polyps  with  more
han  10  mm,  and  all  hyperplastic  polyps  with  more  than
 mm  should  be  removed.23 In  the  case  of  multiple  polyps,
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he  greater  ones  should  be  removed  by  polypectomy,  and
epresentative  samples  of  smaller  polyps  must  be  obtained.
gain,  the  following  approach  will  be  determined  by  the
istology.4
Once  the  hyperplastic  polyps  and  adenomas  are  asso-
iated  with  atrophic  gastritis  and  H.  pylori  infection,  the
pparently  normal  mucosa  of  the  antrum  and  body  must
e  submitted  to  biopsy  (by  adopting  one  of  the  strategies
escribed  in  the  environmental  metaplastic  atrophic  gastri-
is)  to  evaluate  the  stage  of  gastritis  and,  consequently,  the
isk  of  cancer.  Patients  with  evidence  of  H.  pylori  infection
hould  be  treated.2
Gastric  NETs  are  classiﬁed  into  3  types,  according  to  their
athogenesis.  The  types  I  and  II  are  associated  with  the  pres-
nce  of  hypergastrinemia,  which  can  be  primary  (type  II)  or
econdary  to  chronic  atrophic  gastritis  (type  I).  These  two
ypes  of  NETs  can  be  treated  conservatively  because  their
ourse  is  usually  benign.  However,  the  type  III  gastric  NETs
s  more  aggressive,  sporadic  and  develops  in  the  context
f  normal  levels  of  serum  gastrin.  These  tumors  should  be
esected,  usually  by  surgery.  Therefore,  if  there  is  suspicion
f  NETs,  gastric  biopsies  in  initial  endoscopy,  together  with
he  determination  of  serum  gastrin  will  make  the  differenti-
tion  between  the  various  existing  types  and  will  inﬂuence
he  subsequent  approach.24
.9.  Peptic  ulcer  disease
astric  and  duodenal  ulcers  share  many  characteristics
n  particular  in  terms  of  pathogenesis,  diagnosis  and
reatment.25 However,  while  a  duodenal  ulcer  rarely
resents  with  malignant  features,  gastric  ulcers  often  rep-
esent  malignant  ulcerated  neoplasms.  Therefore,  it  is
ecommended  to  perform  multiple  biopsies  (≥8)  in  the  base
nd  edges  of  gastric  ulcers  if  there  is  suspicion  of  malignancy
r  if  the  endoscopy  characteristics  suggest  such  diagnosis.4
n  exfoliative  cytology  may  be  complementary  to  biopsy.2
he  gastric  ulcers  deserve  endoscopic  control  until  full  heal-
ng,  as  it  is  proven  that  the  failure  to  comply  with  this
ecommendation  is  associated  with  missed  cancers.26 In  the
resence  of  peptic  ulcer  disease  it  is  mandatory  to  search
or  H.  pylori  infection,  as  previously  described.
The  gastric  adenocarcinoma  of  diffuse  type  is  less  com-
on,  but  can  occur  without  changes  in  the  mucosa.  In  these
ases,  the  presence  of  suspicious  signs  (low  distensibility  and
uggestive  clinical  context)  should  lead  to  biopsies.4
.10.  Celiac  disease
iopsies  in  the  small  intestine  are  required  for  the  establish-
ent  of  a  suspected  diagnosis  of  celiac  disease,  being  the
ain  indication  for  biopsy  in  the  duodenum.  The  biopsies
hould  be  performed  in  patients  with  symptoms  and  lab-
ratory  abnormalities  suggestive  of  malabsorption  and/or
utrient  deﬁciency  with  positive  anti-celiac  antibodies.27
ince  the  clinical  presentation  of  celiac  disease  is  often  sub-
le,  it  is  important  that  the  threshold  for  biopsy  be  relatively
ow.28
The  implementation  of  multiple  biopsies  from  various
ocations  prevents  inadequate  sampling  due  to  the  discon-
inuous  nature  of  the  distribution  of  histological  changes,
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nd  there  is  some  evidence  that  the  duodenal  bulb  is  less
ffected  by  this  non-uniform  distribution.4 As  such,  it  is  rec-
mmended  to  perform  four  to  six  biopsies  of  the  duodenal
ulb  and  distal  duodenum,  which  must  be  placed  in  sep-
rate  containers,  regardless  of  the  macroscopic  ﬁndings.2
imilarly,  in  the  absence  of  a  suspected  diagnosis  of  celiac
isease  in  the  presence  of  minor  abnormalities  of  the  duo-
enal  mucosa,  biopsies  are  not  indicated.
. Lower endoscopy
.1.  Microscopic  colitis
he  suspicion  of  microscopic  colitis  is  the  main  reason  for
onducting  biopsies  in  the  colon  in  the  presence  of  a  nor-
al  mucosa.29,30 Two  distinct  forms  of  microscopic  colitis  are
escribed:  collagenous  colitis  and  lymphocytic  colitis.  Histo-
ogically,  the  collagenous  colitis  presents  two  main  ﬁndings:
ncreased  subepithelial  deposition  of  collagen  and  intraep-
thelial  lymphocytic  inﬁltration  (this  ﬁnding  alone  deﬁnes
ymphocytic  colitis).  Microscopic  colitis  is  more  common  in
omen,  and  is  usually  diagnosed  in  the  sixth  or  seventh
ecade  of  life  in  the  context  of  watery  chronic  diarrhea
identiﬁed  in  up  to  20%  of  these  cases).31 Although  the  etiol-
gy  of  microscopic  colitis  is  not  fully  deﬁned,  there  is  a  clear
ssociation  with  the  intake  of  NSAIDs  and,  more  recently,
nd  with  celiac  disease  (that  should  always  be  excluded  in
his  situation).30
Colonoscopy  should  be  the  preferred  approach  since
iopsies  of  the  distal  colon  and  rectum  does  not  always
eveal  diagnostic  ﬁndings.32 In  this  case,  it  must  include
wo  or  more  biopsies  of  the  ascending  colon,  two  or  more
iopsies  of  the  transverse  colon,  two  or  more  biopsies  of
he  descending  colon  and  two  or  more  biopsies  of  sigmoid
olon.2 As  an  alternative  strategy  three  to  four  biopsies
f  both  the  right  colon  and  the  left  colon  should  be
erformed.30
.2.  Inﬂammatory  bowel  disease  --  diagnosis
n  patients  with  suspected  inﬂammatory  bowel  disease  (IBD)
he  endoscopic  studies  are  usually  reserved  for  patients  with
isease  apparently  slight  to  moderate.33 Obtaining  biopsies
uring  the  colonoscopy  is  mandatory,  regardless  of  the  addi-
ion  of  time  or  potential  risks.  Biopsies  are  fundamental  for
iagnostic  conﬁrmation  and  for  the  determination  of  the
xtent  of  the  disease,  information  that  is  fundamental  to
he  deﬁnition  of  the  therapeutic  strategy.  However,  biopsies
lone  are  not  sufﬁcient  for  deﬁnitive  diagnosis,  and  their
esults  should  be  integrated  into  clinical  context.34
Ileocolonoscopy  is  the  endoscopic  examination  recom-
ended  in  all  patients,  and  two  or  more  biopsies  in  ﬁve
ifferent  locations,  including  the  ileum  and  rectum  should
e  obtain.35 In  the  presence  of  macroscopic  changes,  it
s  recommended  that  the  biopsies  be  performed  in  areas
pparently  involved  by  disease  and  in  the  mucosa  of  normal
ppearance  around,  and  they  should  be  separated  and  iden-
iﬁed  from  proximal  to  distal.2 In  the  presence  of  ulcerated
esions,  two  or  more  tissue  samples  should  be  labeled  sep-
rately  for  the  identiﬁcation  of  viral  inclusions;  moreover,
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biopsies  from  the  edges  of  ulcers  or  aftoid  erosions  increase
the  detection  rate  of  granulomas.30
If  there  is  suspicion  of  upper  digestive  tract  involvement,
it  should  be  considered  an  upper  endoscopy  with  two  or  more
biopsies  of  the  esophagus,  stomach  and  duodenum.36
3.3.  Inﬂammatory  bowel  disease  --  screening  of
dysplasia
The  endoscopic  surveillance  of  colonic  dysplasia  is  currently
recommended  in  patients  with  long-term  ulcerative  colitis
or  Crohn’s  colitis,  and  should  be  initiated  8--10  years  after
the  diagnosis  of  a  pancolitis  and  12--15  years  after  the  diag-
nosis  of  a  left  colitis.37,38
Taking  into  account  the  present  evidence,  chromoen-
doscopy  with  targeted  biopsies  should  be  the  global
approach  in  the  near  future.  If  there  is  a  gastroenterolo-
gist  with  experience  in  performing  chromoendoscopy,  this
technique  should  be  prioritized.  It  is  recommended  that  the
additional  biopsies  in  all  segments  of  the  colon  should  be
made  to  assess  the  presence  and  degree  of  inﬂammation.
The  observance  of  this  technique  is  associated  with  a  detec-
tion  rate  of  dysplasia  3  times  greater  than  that  described  for
the  protocol  of  random  biopsies.30
However,  in  the  majority  of  centers,  the  protocol  of
random  biopsies  remains  as  the  endoscopic  approach.  In
the  case  of  pancolitis,  it  is  recommended  biopsies  of  the
four  quadrants  each  10  cm  from  the  cecum  to  the  rectum,
with  a  minimum  number  of  33  biopsies.2 In  the  absence  of
pancolitis,  it  is  recommended  to  perform  biopsies  of  the
four  quadrants  each  10  cm  limited  to  areas  with  endoscopic
or  histological  involvement  in  previous  examinations.39 Any
lesion  suspected  of  containing  dysplasia  should  be  submit-
ted  to  biopsy  or,  ideally,  removed,  and  the  surrounding
mucosa  should  also  be  sampled  if  involved  by  inﬂamma-
tory  disease.30 The  ileocecal  valve  should  not  be  subject  to
biopsies  if  macroscopically  normal.
3.4.  Pouchitis
Pouchitis  is  the  main  complication  in  patients  with  ulcerative
colitis  undergoing  proctocolectomy  with  ileo-anal  anasto-
mosis,  occurring  in  30--50%  of  cases.  Patients’  complaints
involve  abdominal  cramps,  urgency,  night  incontinence,
and  fever.  Patients  with  symptoms  of  pouchitis  after
proctocolecomy  should  be  submitted  to  endoscopy  with
multiple  biopsies  of  the  ileo-anal  pouch  and  afferent
loop.  In  the  presence  of  macroscopic  changes  on  the
afferent  loop,  the  possibility  of  a  Crohn’s  disease  should
be  considered,  and  the  diagnosis  can  be  conﬁrmed  by
histology.40
3.5.  Polypoid  lesions  of  colon
Most  colo-rectal  cancers,  regardless  of  its  etiology,  come
from  adenomatous  polyps,  of  which  only  a  minority  become
malignant  (<1%).  Adenomas  are  identiﬁed  in  approximately
30%  of  middle-aged  individuals  and  in  approximately  50%  of
the  elderly  population.  Colonoscopy  is  considered  the  best
approach  for  screening  and  prevention  of  colorectal  cancer.
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linically,  the  likelihood  of  an  adenomatous  polyp  evolve  for
ancer  depends  on  its  macroscopic  appearance,  its  dimen-
ions,  and  the  histological  characteristics.41
As  a general  rule,  polypoid  lesions  are  excised  and  not
ubmitted  to  biopsy.  Small  lesions  (<5  mm)  can  be  removed
ith  a  forceps  biopsy  or  through  polypectomy.  Lesions  of
arger  dimensions  can  be  removed  by  polypectomy  or  muco-
ectomy,  if  technically  possible.30 This  approach  allows  a
ore  deﬁnitive  histopathological  evaluation,  and  can  be
urative.  Biopsies  in  lesions  with  a  high  probability  of  being
ubsequently  submitted  to  endoscopic  resection  can  pro-
ote  the  development  of  submucosal  ﬁbrosis  and  ﬁx  lesions
reviously  deployable.  In  addition,  it  should  always  be  con-
idered  the  potential  variability  of  biopsies  that  may  not
e  able  to  identify  foci  of  adenocarcinoma  in  lesions  of
arge  dimensions.  In  these  cases  it  should  be  considered
he  primary  excision  of  the  lesions.  Furthermore,  this  atti-
ude  decreases  the  risk  of  ‘‘contaminate’’  biopsies  of  other
enign  lesions  with  possible  foci  of  adenocarcinoma  of
reater  risk  lesions.30
.6.  Acute  graft  versus  host  disease
he  ideal  endoscopic  approach  is  not  deﬁned.  Rectum  and
istal  colon  are  the  sites  with  the  highest  sensitivity,  even
n  patients  with  symptoms  suggestive  of  involvement  of
he  upper  digestive  tract.42,43 Two  potential  approaches  are
escribed  in  the  literature.2 The  ﬁrst  involves  the  imple-
entation  of  a  ﬂexible  sigmoidoscopy  with  four  or  more
iopsies  in  the  rectum/sigmoid  and  four  or  more  biopsies
n  left  colon.  If  the  sigmoidoscopy  is  not  diagnostic,  it  is
uggested  to  perform  an  upper  endoscopy  with  four  or  more
iopsies  in  the  gastric  antrum  and  body  and  duodenum,  and
ay  also  be  considered  the  distal  esophagus.  The  second
pproach  is  to  conduct  an  ileocolonoscopy  with  four  or  more
iopsies  in  the  terminal  ileum,  four  or  more  biopsies  in  the
ight  colon,  four  or  more  biopsies  in  the  transverse  colon,
our  or  more  biopsies  in  the  left  colon  and  four  or  more
iopsies  in  the  rectum/sigmoid.
.  Conclusion
his  review  seeks  to  condense  the  existing  evidence
oncerning  the  performing  of  biopsies  in  gastrointestinal
ndoscopy,  focusing  on  the  precise  diagnosis  of  the  most
ommon  gastrointestinal  diseases  that  motivate  endoscopic
xaminations  through  the  rational  use  of  resources,  without
ompromising  the  proper  follow-up  of  patients.  In  addition,
t  also  describes  situations  in  which  the  histopathologi-
al  evaluation  may  not  be  justiﬁable  by  its  low  sensitivity
nd  speciﬁcity,  in  addition  to  possibly  unnecessary  costs.
he  development  of  policies  together  with  the  pathologic
epartment  it  is  fundamental  to  the  effective  establishment
f  these  practices.rotection  of  human  and  animal  subjects.  The  authors
eclare  that  no  experiments  were  performed  on  humans  or
nimals  for  this  study.
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